Lv6
2330 积分 2023-05-11 加入
Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer
2小时前
待确认
A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma
16天前
已完结
IL-2Rα-biased agonist enhances antitumor immunity by invigorating tumor-infiltrating CD25+CD8+ T cells
10个月前
已完结
Cytokines that target immune killer cells against tumors
1年前
已完结
An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma
1年前
已完结
Children's Oncology Group AALL1331: Phase III Trial of Blinatumomab in Children, Adolescents, and Young Adults With Low-Risk B-Cell ALL in First Relapse
1年前
已完结
CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
1年前
已完结
Targeting CD19: the good, the bad, and CD81
1年前
已完结
Bispecific Antibodies for Non-Hodgkin Lymphoma Treatment
1年前
已完结
A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL
1年前
已完结
皖公网安备34019202002308
